The center of gravity in the global pharmaceutical industry is shifting. While traditional Western markets grapple with pricing caps and maturing pipelines, the pharma market in MENA has emerged as a high-octane engine of growth. In 2026, we are no longer talking about “potential.” We are witnessing a full-scale transformation. Driven by aggressive sovereign wealth […]
As we navigate the first quarter of 2026, the Gulf Cooperation Council (GCC) has solidified its position as one of the most dynamic pharmaceutical landscapes globally. With the regional market valuation surpassing USD 17 billion this year, the influx of international brands seeking entry into Saudi Arabia, the UAE, and neighboring states has reached an […]
The growing global demand for pharmaceuticals has forced manufacturers to look beyond saturated markets. With the global pharma market projected to exceed $2.1 trillion in 2026, the need for resilient supply chains and proximity to emerging markets is paramount. In this context, Gulf countries as emerging pharma hubs have successfully positioned themselves as the next […]
In the rapidly evolving global healthcare landscape of 2026, the corridors of commerce between the Mediterranean and the Arabian Gulf have become vital lifelines for global health. The Pharma trade between Middle East and Europe has transcended traditional transactional relationships, evolving into a sophisticated ecosystem of innovation and resilience. As global health demands shift, the […]
The UAE’s pharma industry in UAE is exploding, valued at USD 4.15 billion in 2024 and projected to reach USD 8.02 billion by 2033 with a 7.3% CAGR. This surge reflects booming demand for quality medicines amid rising chronic diseases like diabetes and cardiology issues affecting 20% of the population. Pharmaceutical investment in UAE isn’t […]
The Gulf region’s healthcare landscape has undergone an immense transformation over the past decade. As populations surge and chronic conditions rise, demands for high-quality yet affordable healthcare services have never been greater. Central to this evolution are the Gulf Pharmaceutical Industries, which are reimagining both supply chains and care delivery through local innovation and strategic […]
In the last decade, the pharmaceutical companies in UAE has become a vital driver of the Middle East’s healthcare and life sciences industry. A former trading centre is now turning into a regional pharmaceutical hub, powering innovation, production, and efficient medicine distribution. As demand for affordable, high-quality healthcare increases in GCC and MENA nations, the […]
The availability of Clobazam Oral Suspension (Zacco) has now been officially registered in Bahrain, strengthening access to reliable neurological and psychiatric treatment options across the region.This registration marks a key advancement in ensuring that patients and healthcare professionals in Bahrain can access a high-quality, sugar-free, and alcohol-free formulation of Clobazam, developed to improve dosing flexibility […]
The United Arab Emirates stands as a regional hub in the Middle East’s expanding healthcare sector. The market size for pharmaceuticals in the UAE reached USD 4.15 billion in 2024 and is forecasted to grow to USD 8.02 billion by 2033 at a CAGR of 7.3%. Rising investments, an increase in chronic disease prevalence, and […]
As the Middle East and Gulf pharmaceutical market exceeds $40 billion in value and accounts for some of the world’s fastest-growing pharmaceutical supply chains in 2025, the need to ensure your medicines are supplied by a trusted pharmaceutical distributor has never been more urgent. The World Health Organization estimates that up to 10% of medicines […]